Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.

[1]  Erin Burns,et al.  Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. , 2016, MMWR. Morbidity and mortality weekly report.

[2]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[3]  C. Reed,et al.  Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States, 2013–14 Influenza Season , 2014, MMWR. Morbidity and mortality weekly report.

[4]  H. Kelly,et al.  Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match , 2014, Journal of medical virology.

[5]  D. Skowronski,et al.  Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  A. Monto,et al.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Reed,et al.  Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination — United States, 2012–13 Influenza Season , 2013, MMWR. Morbidity and mortality weekly report.

[8]  B. Cowling,et al.  Influenza Transmission in a Cohort of Households with Children: 2010-2011 , 2013, PloS one.

[9]  L. Grohskopf,et al.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[10]  Carrie Reed,et al.  Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011 , 2013, PloS one.

[11]  Lynnette Brammer,et al.  Influenza Activity — United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine , 2013, MMWR. Morbidity and mortality weekly report.

[12]  Jennifer C Nelson,et al.  The test-negative design for estimating influenza vaccine effectiveness. , 2013, Vaccine.

[13]  R. Borse,et al.  Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010 , 2013, Emerging infectious diseases.

[14]  M. Valenciano,et al.  Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  S. Wisniewski,et al.  Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013 , 2013, MMWR. Morbidity and mortality weekly report.

[16]  A. Ciapponi,et al.  Burden of influenza in Latin America and the Caribbean: a systematic review and meta‐analysis , 2012, Influenza and other respiratory viruses.

[17]  L. Brammer,et al.  Estimating influenza incidence and rates of influenza‐like illness in the outpatient setting , 2012, Influenza and other respiratory viruses.

[18]  Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine. , 2012, MMWR. Morbidity and mortality weekly report.

[19]  Vaccines against influenza WHO position paper – November 2012. , 2012, Releve epidemiologique hebdomadaire.

[20]  Harish Nair,et al.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis , 2011, The Lancet.

[21]  B. Gessner,et al.  Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review. , 2011, The Lancet. Infectious diseases.

[22]  M. Ebell,et al.  A Systematic Review of Clinical Decision Rules for the Diagnosis of Influenza , 2011, The Annals of Family Medicine.

[23]  Marc Lipsitch,et al.  Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009 , 2009, Emerging infectious diseases.

[24]  M. Jackson.  Confounding by season in ecologic studies of seasonal exposures and outcomes: examples from estimates of mortality due to influenza. , 2009, Annals of epidemiology.

[25]  R. Greenlee,et al.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.

[26]  Cecile Viboud,et al.  Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data. , 2006, American journal of epidemiology.

[27]  R. Greenlee.  Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). , 2003, Clinical medicine & research.

[28]  A. Bradford.  The Australian Immunisation Handbook , 2000 .

[29]  A. Monto,et al.  Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. , 1995, American journal of epidemiology.

[30]  J. Mullooly,et al.  Underestimation of the role of pneumonia and influenza in causing excess mortality. , 1981, American journal of public health.

[31]  R. Serfling.  Methods for current statistical analysis of excess pneumonia-influenza deaths. , 1963, Public health reports.